A STUDY OF PrEP SERVICE MODEL FOR HIV PREVENTION IN THE PUBLIC HEALTH SERVICE SYSTEM
DOI:
https://doi.org/10.14456/taj.2022.9Keywords:
Pre-Exposure Prophylaxis (PrEP), HIV, Public Health Service SystemAbstract
The first objective was to study the factors affecting to patterns of provision services promoting preventive medication before HIV exposure among staffs in the public health services. Second, to obtain the staff’s opinions and recommendations on the factors contributing to the success and obstacles in the provision of HIV Pre-Exposure drug services in high risk behavior. Of 67 participants completed the questionnaire and participate in the focus group. The procedure began with descriptive statistics analysis and content analysis. In this study found that there are five factors for providing PrEP services. Firstly, policies from both central and service units should be consistent, continuing, and unidirectional particularly in reporting format and monitoring service engagement. Secondly, proactive networks play a role as significant factor for screening target groups involve in risky behaviors. Thirdly, online media such as website or social media approach directly to target groups with high-risk behaviors Moreover, online media is able to answer questions and educate people in HIV prevention. Fourthly, staff in service providers should have a friendly personality and pay attention to client adherence to the service system. The PrEP service team and antiretroviral clinic should be the same team because both of them need HIV knowledge equally. However, fifthly, service unit should be in a good location. PrEP services should be organized separately from the antiretroviral clinic. There are public relations and activities to search for clients with risk behaviors should be created in order to decrease new cases. With regarding to the study, four recommendations were mentioned. First ofall, increase public relations and campaign to decrease stigma and discrimination should be designed for population level, avoiding focus on specific groups. Second, Intimate and privacy should be concerned as the main point for service, separated from other departments. Third, digital queuing system such as sending a Short Message Service (SMS) may reduce waiting time. Finally, providing all staff with training in sensitivity issues related to PrEP at clinic is still essential.
Downloads
References
National AIDS Committee. Global AIDS Monitoring report 2018 (GAM report 2018). Pornthip Khemngern, Dusita Puengsamran, Thanapol Chaiprateep, editors. 1st edition. Bangkok: NC Concept Co., Ltd.; 2018. (in Thai)
National Committee for the Prevention and Response to AIDS. Action plan to end AIDS problems in Thailand 2015-2019. Bangkok: NC Concept Co., Ltd.; 2014. (in Thai)
World Health Organization. Guidance on pre-exposure oral prophylaxis (PrEP) for Sero discordant couples, men and trans-gender women who have sex with men at high risk of HIV: Recommendations for use in the context of demonstration projects. The United States of America: World Health Organization; July 2012.
Bureau of AIDS, Tuberculosis and Sexually Transmitted Infection, Department of Disease Control. Thailand National Guidelines on HIV/ AIDS Treatment and Prevention 2014 (portable edition). Bangkok: Agricultural Cooperative Society of Thailand Limited Printing House; 2014. (in Thai)
Bureau of AIDS, Tuberculosis and Sexually Transmitted Infection, Department of Disease Control. Thailand National Guidelines on Pre-exposure prophylaxis: HIV-PrEP 2018. Bangkok: Agricultural Cooperative Society of Thailand Limited Printing House; 2018. (in Thai)
World Health Organization. Consolidated guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations, Geneva: World Health Organization; 2014.
Robert M. Grant, Javier R. Lama, Peter L. Anderson, Vanessa McMahan, Albert Y. Liu, Lorena Vargas, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27): 2587-99.
Alison J. Rodger, Valentina Cambiano, Tina Bruun, Pietro Vernazza, Simon Collins, Jan van Lunzen, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV positive partner is using suppressive antiretroviral therapy. JAMA. 2016; 316(2): 171-81.
Robert M Grant, Peter L Anderson, Vanessa Mc Mahan, Albert Liu, K Rivet Amico, Megha Mehrotra, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014; 14(9): 820-9. doi: 10.1016/S1473-3099(14) 70847-3.
Kachit Choopanya, Michael Martin, Pravan Suntharasamai, Udomsak Sangkum, Philip A Mock, Manoj Leethochawalit, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013; 381(9883): 2083-90. doi: 10.1016/S0140-6736(13)61127-7.
Amy L. Corneli, Jennifer Deese, Meng Wang, Doug Taylor, Khatija Ahmed, Kawango Agot, et al. Adherence Patterns and Factors Associated with Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis. J Acquir Immune Defic Syndr. 2014; 66(3): 324-31.
Madeline B Deutsch, David V Glidden, Jae Sevelius, Joanne Keatley, Vanessa McMahan, Juan Guanira, et al. HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial. Lancet HIV. 2015; 2(12): e512-e519. doi:10.1016/S2352-3018(15)00206-4.
Sheena McCormack, David T Dunn, Monica Desai, David I Dolling, Mitzy Gafos, Richard Gilson, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilotphase of a pragmatic open-label randomised trial. Lancet. 2016; 387: 53-60. doi: 10.1016/S0140-6736(15)00056-2.
Cheewanan Lertpiriyasuwat, Nittaya Panupak, Vanvipa Wannakit, Supaporn Pengnonyang, Michael Martin, Chomnad Manopaiboon, et al. Outcomes of the Pre-exposure Prophylaxis Antiretroviral Drug Assessment Program
(Pre-exposure prophylaxis of HIV, PrEP) among men who have sex with men and transgender women in Thailand (Pre-exposure prophylaxis of HIV, PrEP) among men who have sex with men and women in Thailand; 26 September 2019; Pharmaceutical Organization meeting room. Bangkok: Government Pharmaceutical Organization; 2019. (in Thai)
Division of AIDS & STIs, Department of Disease Control. Thailand National Guidelines on Pre-exposure prophylaxis: HIV-PrEP 2021. Bangkok: Agricultural Cooperative Society of Thailand Limited Printing House; 2018. (in Thai)
